Answers are grounded in this paper and cite their sources.
asthma, can improve BHR when administered chronically to patients with mild asthma. 19 This research has many parallels with the use of b-blockers in the treatment of patients with heart failure where this class of drug was once contraindicated as acute dosing produced adverse effects in such patients. 20 It was then subsequently recognised that chronic dosing with b-blockers was beneficial in patients with heart failure, and the use of this drug class is now considered a central part of standard treatment guidelines. So-called ''paradoxical pharmacology'', 21 where there may be differential effects of acute versus chronic dosing of a given class of drug, would seem to be a very important issue when considering the use of drugs that recognize the b 2 receptor.
No takes yet. Share an insight, caveat, or question.
Johnston et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: